Productivity & cost gains drive pharmaceutical companies to outsource drug discovery to India and China

摘要

The Indian and Chinese drug discovery outsourcing market is riding a crest,with companies from outside Asia increasingly seeking to outsource drug discovery to these countries for greater cost savings.Other major factors driving this shift to Indian and Chinese companies are the better access to expertise,productivity gains,process improvements,variable costs,avoidance of capital outlays and opportunities for companies to focus on specific niches.